Dmitrii Shek graduated from medical school in 2016. He completed his basic physician training in 2018 and Master of Research (MRes) in 2020. Currently a PhD candidate under the supervision of Professor Golo Ahlenstiel. His project aims to determine clinical and biological risk factors of immune-checkpoint inhibitors toxicity by implementing spatial analysis and single-cell sequencing.